Qlucore AB engages in the provision on information technology systems and solutions. The company is headquartered in Lund, Skane and currently employs 20 full-time employees. The company went IPO on 2021-11-05. The Company’s scope of activity revolves around developing Artificial-Intelligence-based (AI-based) software dedicated to the healthcare sector. The software’s aim is to establish a platform improving cancer care in terms of treatment strategies, and more, as well as other therapy areas. What is more, the Firm develops software which is committed to data analysis in relation to medical research. The Company’s software relies on AI-based machine learning and functions by transforming data sets into explanatory visualizations. Additionally, the Firm runs three software products: Qlucore Omics Explorer, Qlucore Diagnostics, as well as Qlucore Insights.
Follow-Up Questions
¿Quién es el CEO de Qlucore publ AB?
Mr. Carl-Johan Ivarsson es el Chief Executive Officer de Qlucore publ AB, se unió a la empresa desde 2007.
¿Qué tal es el rendimiento del precio de la acción QLUCF?
El precio actual de QLUCF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Qlucore publ AB?
Qlucore publ AB pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Qlucore publ AB?
La capitalización bursátil actual de Qlucore publ AB es $0
